23/11/2007 - The official report into good manufacturing practice (GMP) failures that caused dangerous contamination and a Europe-wide recall of Roche's HIV drug Viracept (nelfinavir) claims the firm simply did not understand its own manufacturing processes.
Link to Article
In-Pharmatechnologist.com
|
|
||||||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Regulators slate Roche 'lack of knowledge and understanding' in Viracept contamination case
No comments found.
|
Search
Links
|
||||||